MB 2/3
BULLETS
Free CME
Join now
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 214657

Aromatase Inhibitors Tamoxifen Clinical use QID: 214657 (M2.OMB.4871)
In scope icon M 7 A
QID 214657 (Type "214657" in App Search)
A 62-year-old woman (patient A) and a 28-year-old woman (patient B) both present for follow-up care after undergoing surgery for breast cancer. The first patient was found to have node-negative, estrogen-receptor (ER)-positive, progesterone-receptor (PR)-negative, and human epidermal growth factor (HER2)-negative breast cancer. She underwent menopause at age 57. The second patient was found to have node-negative, ER-positive, PR-positive, and HER2-negative breast cancer. She is pre-menopausal. Which of the following are the most appropriate treatments to prevent breast cancer recurrence for these patients?
Type in at least one full word to see suggestions list